Future Market Insights predicts that the global Filariasis Treatment market demand will experience a 10.1% compound annual growth rate (CAGR) between 2023 and 2033, with an estimated value of US$ 28.68 billion by 2033. The growth in the market is expected to be driven by the rising prevalence of filariasis, improved diagnostic capabilities, and increased …
Category Archives: Healthcare Trends
Cancer Biopsy Market is projected to increase at a CAGR of around 18% from 2023 to 2033
The Cancer Biopsy market revenues were estimated at US$ 22.2 Bn in 2022 and is anticipated to grow at a CAGR of 18% from 2023-2033, according to a recently published Future Market Insights report. By the end of 2033, the market is expected to reach US$ 131.4 Bn. The increasing elderly populace, along with the rise in instances of cancer diagnoses, is …
NGS Sample Preparation Market is projected to advance at a CAGR of 13.7% from 2022 to 2032 | FMI Study
[342 Pages Report] The global NGS sample preparation market is expected to be valued at $5441.1 million by 2032, up from $1321.8 million in 2022, and to grow at a 13.7% CAGR during the forecast period (2022-2032). DNA contains the blueprints of life. Within its structures are the codes required for the assembly of proteins and non-coding …
Pancreatic Cancer Market is projected to accelerate at a CAGR of 13.5% to top US$ 7,541.09 Million by 2033
In 2023, the market for pancreatic cancer will be worth over US$2,125,57 million. By 2033, it is anticipated that the market for pancreatic cancer would grow at a CAGR of 13.5% and reach $7,541.09 million. The seventh greatest cause of cancer-related deaths worldwide, pancreatic cancer is one of the most often diagnosed cancers. In the West, pancreatic …
Age Related Molecular Degeneration Market is likely to propel to US$ 22.19 Million by 2033 | Exclusive Report by FMI
The global age-related molecular degeneration market is currently valued at US$ 11.28 Million in 2023 and is anticipated to expand at a CAGR of 7%. Owing to the technological advances in healthcare the market is likely to propel to US$ 22.19 Million by 2033. The increasing prevalence of AMD and a strong product pipeline are …
Extracorporeal CO2 Removal Devices Market is anticipated to expand at a CAGR of 5.8% from 2022 to 2032
According to Future Market Insights’ newly released Extracorporeal CO2 Removal Devices Market industry analysis report, global sales of the Extracorporeal CO2 Removal Devices Market in 2021 will be US$ 91.6 Million. The market is expected to reach a valuation of US$ 170.9 Million by 2032, with a CAGR of 5.8% between 2022 and 2032. Extracorporeal CO2 Machines …
Lyophilized Injectable Market is currently valued at US$ 3043.55 Million in 2023 | FMI
The global Lyophilized Injectable Market is expected to grow at a steady 5.8% over the next few years. In 2023, the lyophilized injectable market is expected to be worth $3043.55 million. Demand for lyophilized injectables is expected to reach a peak of US$ 5348.56 Mn by 2033. Because of their stability at room temperature, lyophilized medications are …
Wheelchairs Market to reach a valuation of ~US$ 7.9 Billion by the year 2032, at a CAGR of 3.2% from 2022 to 2032
As per Future Market Insights’ latest industry analysis, the valuation for the global wheelchairs market was around US$ 5.5 Bn in 2021, and is projected to exhibit growth at a CAGR of close to 3.2% over the forecast period. Market Outlook: Data Points Market Insights Market Value 2021 US$ 5.5 Billion Market Value 2022 US$ 5.7 Billion Market Value 2032 US$ …
Kidney Transplant Market is anticipated to rise at a CAGR of 4.2% from 2023 to 2033 | FMI Study
As per Future Market Insights’ latest industry analysis, the valuation for the global Kidney Transplant Market was around US$ 5.8 Billion in 2022 and is projected to exhibit a CAGR of 4.2% over the forecast period, with an estimated valuation of US$ 9.1 Billion in 2033. The global burden of chronic kidney diseases is increasing at a higher rate. One of just a …
Cell Therapy Manufacturing Market size is anticipated to reach a valuation of ~US$ 13.9 Billion by 2032, at a CAGR 14.2% from 2022 to 2032
As per Future Market Insights’ latest industry analysis, the valuation of the global cell therapy manufacturing market was around US$ 3.3 Bn in 2021, and is projected to exhibit a CAGR of close to 14.2% over the forecast period. The market is expected to reach US$ 13.9 Bn in 2032. Cell therapies are utilized widely to treat viral infections, cancer, hemoglobinopathies, and hereditary immunological disorders. Introduction …